glp 1 agonist saxenda Q&A: Understanding Benefits, Managing Adverse Effects of GLP-1 Receptor Agonists Saxenda (liraglutide): Uses, Side Effects,

doi:10.1056/NEJMoa2301972 PubMed: This landmark study demonstrated 24.2% mean weight loss at 48 weeks with the 12mg dose in 338 adults with obesity, establishing retatrutide as the most effective obesity medication tested to date

IGF-1 is a major downstream mediator of GH signaling and is involved in anabolic signaling, tissue remodeling, and metabolic regulation. In healthy-adult studies, CJC-1295 with DAC produced sustained increases in both GH and IGF-1. This is one of the strongest direct human research findings for the CJC-1295 category

It actually has anabolic activity and it's nutrient partitioning is par non

Biol Trace Element Res (1992) 32:2538

Renz, H., Brandtzaeg, P